Background:
Ibrutinib is associated with atrial fibrillation (AF), though
echocardiographic predictors of AF have not been studied in this
population. We sought to determine whether left atrial (LA) strain on
transthoracic echocardiography could identify patients at risk for
developing ibrutinib-related atrial fibrillation (IRAF).